Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026)
Cadrenal Therapeutics (CVKD) recorded Shares Outstanding (Entity) of 3.1 million in Q2 2026, up 54.4% from 2.01 million a year earlier and up 23.6% from the prior quarter.
Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends
For FY2025, Cadrenal Therapeutics reported Shares Outstanding (Entity) of 2.34 million, up 91.7% from FY2024.
- Annual Shares Outstanding (Entity) has increased for three straight years, with a three-year compound annual growth rate of 62.4% (FY2022 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 1.22 million in FY2024 (+40.5%), 868,227 in FY2023 (+58.9%) and 546,286 in FY2022.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2022.
- On a year-over-year basis, Shares Outstanding (Entity) has increased for 14 consecutive quarters, with growth averaging 61.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 31.3% in Q1 2026 to 91.7% in Q4 2025.
- Per Business Quant, the preceding three quarters came in at 2.51 million (Q1 2026), 2.34 million (Q4 2025) and 2.06 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Cadrenal Therapeutics | 557,746.58 | -12.06 Mn | - | 387,324.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 387,324.00 |
| Mar 31, 2026 | 417,803.00 |
| Dec 31, 2025 | 389,688.00 |
| Sep 30, 2025 | 343,292.00 |
| Jun 30, 2025 | 334,519.00 |
| Mar 31, 2025 | 318,289.00 |
| Dec 31, 2024 | 203,258.00 |
| Sep 30, 2024 | 205,779.00 |
| Jun 30, 2024 | 177,881.00 |
| Mar 31, 2024 | 177,881.00 |
| Dec 31, 2023 | 144,704.00 |
| Sep 30, 2023 | 144,704.00 |
| Jun 30, 2023 | 130,259.00 |
| Mar 31, 2023 | 130,259.00 |
| Dec 31, 2022 | 91,048.00 |
| Sep 30, 2022 | 90,303.00 |
| Jun 30, 2022 | 88,338.00 |
| Mar 31, 2022 | 83,338.00 |
Cadrenal Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CVKD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();